Net Loss Per Share - Schedule of Outstanding Shares Potentially Dilutive Securities (Details) - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items] | ||
| Antidilutive Securities | 179,413,500 | 6,126,863 |
| Options to purchase common stock [Member] | ||
| Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items] | ||
| Antidilutive Securities | 13,671,140 | 10,302,086 |
| Warrants to purchase common stock [Member] | ||
| Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items] | ||
| Antidilutive Securities | 4,784,193 | 4,784,193 |
| Warrants to purchase convertible preferred stock [Member] | ||
| Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items] | ||
| Antidilutive Securities | 160,958,167 | 160,958,167 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|